Ellence Articles
Pfizer and Teva resolve two law suits
27 November 2006
P&U continues turnaround, looking for 1999 double-digit growth
29 October 1999
P&U's Aromasin approved by FDA
28 October 1999
Epirubicin cleared in USA for node-positive early breast cancer
21 September 1999
Showing 1-5 of 5 articles
- 1
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
